Medical oversight can improve screening, informed consent, product sourcing, monitoring, and response to adverse events, but it cannot turn limited evidence into established proof
18: Chemistry, manufacturing and controls issues cost Satsuma Pharmaceuticals as the FDA issued a Complete Response Letter for its nasal powder migraine drug, STS101, according to a Thursday press release by parent company Shin Nippon Biomedical Laboratories
In a recent study, epitalon was tested on normal cells and breast cancer cells
High-dose B12 therapy can also boost nerve function and reduce pain
#SleepMedicine #SleepScience #Insomnia #SleepResearch #Neuroscience #SleepHealth Empower Sleep To view or add a comment, sign in More Relevant Posts Sleep: The Foundation of Brain Health We often think of sleep as a period of recovery or rest